ABC of COPDGraeme P. Currie Chronic Obstructive Pulmonary Disease (COPD) is a progressive, largely irreversible lung condition characterised by airflow obstruction. Although cigarette smoking is the single most important risk factor in its development, other associations and risk factors are thought to have increasing relevance throughout the world. COPD is usually managed in primary care, although it is commonly under-diagnosed, and is one of the most common medical conditions necessitating admission to hospital. The second edition of the ABC of COPD provides the entire multidisciplinary team with a reliable, up-to-date and accessible account of COPD. Extensively updated by experienced clinicians - including new chapters on spirometry, inhalers, oxygen, death, dying and end of life issues - this ABC is an authoritative and practical guide for general practitioners, practice nurses, specialist nurses, medical students, paramedical staff, junior doctors, non-specialist doctors and all other health professionals working in both primary and secondary care. |
Contents
Pathology and Pathogenesis | |
Diagnosis Clinical Features | |
FlowvolumeMeasurement How to PerformSpirometry Contraindications to Spirometry Accuracy and Quality of Traces | |
Chapter | |
Pharmacological Management I Inhaled | |
ShortactingBronchodilators Longacting Bronchodilators | |
Pharmacological Management II Oral Treatment | |
Exacerbations | |
Investigations | |
Prevention of Exacerbations | |
Noninvasive Ventilation | |
Primary Care | |
Why Perform Spirometry? | |
Smoking Cessation | |
DeathDying and EndofLife Issues MaintainingQuality ofLife | |
Triple Therapy | |
Oxygen | |
Future Treatments | |
Other editions - View all
Common terms and phrases
Aberdeen Royal Infirmary acute exacerbations adverse effects agonist airway antibiotics anticholinergic antiinflammatory associated asthma breathlessness bronchodilators Bullectomy bupropion chronic obstructive pulmonary cigarette smoking clinical Cochrane Database contraindications COPD Database of Systematic device diagnosis drug European Respiratory exacerbation of COPD exacerbations of chronic exercise Figure flow rate fluticasone forced expiratory volume formoterol Further reading Handihaler hospital hyperinflation improve increased individuals inflammation inflammatory Influenza inhaled corticosteroids inhibitors inpatients inthe Lancet longacting anticholinergic longacting bronchodilators LTOT lung function Medicine metaanalysis metered dose inhaler mouthpiece muscle nasal nebulised bronchodilators neutrophils nicotine noninvasive ventilation obstructive pulmonary disease ofCOPD oral corticosteroids patients with COPD patientswith pharmacological placebo pMDIs pneumonia portable predicted prescribed pulmonary disease COPD pulmonary rehabilitation Pulse oximeters randomised reduce respiratory acidosis roflumilast salmeterol shortacting shouldbe smoking cessation spacer spirometry sputum studies symptoms Systematic Reviews theophylline Thorax tiotropium treatment Turbohaler UK Overview vaccination varenicline